{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:33:19Z","timestamp":1791196399674,"version":"4.1.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s11060-009-9867-7","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T14:51:46Z","timestamp":1241794306000},"page":"61-77","source":"Crossref","is-referenced-by-count":51,"title":["Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma"],"prefix":"10.1007","volume":"93","author":[{"given":"Scott R.","family":"Plotkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Halpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishri O.","family":"Blakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William H.","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Bradley","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon J.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Gregory","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Fred G.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,9]]},"reference":[{"key":"9867_CR1","unstructured":"Central Brain Tumor Registry of the United States (2008) Statistical Report: primary brain tumors in the United States, 2000\u20132004. CBTRUS, Hinsdale, IL"},{"key":"9867_CR2","volume-title":"Modern management of acoustic neuroma","year":"2008","unstructured":"Regis J, Roche P-H (eds) (2008) Modern management of acoustic neuroma. Karger, Basel"},{"key":"9867_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26:93\u201397. doi:\n                    10.1097\/00129492-200501000-00016","journal-title":"Otol Neurotol"},{"key":"9867_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/jmg.29.12.841","volume":"29","author":"DG Evans","year":"1992","unstructured":"Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841\u2013846. doi:\n                    10.1136\/jmg.29.12.841","journal-title":"J Med Genet"},{"key":"9867_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1097\/00005537-200308000-00013","volume":"113","author":"FG Barker II","year":"2003","unstructured":"Barker FG II, Carter BS, Ojemann RG, Jyung RW, Poe DS, McKenna MJ (2003) Surgical excision of acoustic neuroma: patient outcome and provider caseload. Laryngoscope 113:1332\u20131343. doi:\n                    10.1097\/00005537-200308000-00013","journal-title":"Laryngoscope"},{"key":"9867_CR6","first-page":"603","volume":"84","author":"DG Evans","year":"1992","unstructured":"Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603\u2013618","journal-title":"Q J Med"},{"key":"9867_CR7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3171\/jns.2003.99.3.0480","volume":"99","author":"G Otsuka","year":"2003","unstructured":"Otsuka G, Saito K, Nagatani T, Yoshida J (2003) Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. J Neurosurg 99:480\u2013483","journal-title":"J Neurosurg"},{"key":"9867_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1086\/342716","volume":"71","author":"ME Baser","year":"2002","unstructured":"Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DG (2002) Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71:715\u2013723. doi:\n                    10.1086\/342716","journal-title":"Am J Hum Genet"},{"key":"9867_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/00006123-199704000-00007","volume":"40","author":"M Samii","year":"1997","unstructured":"Samii M, Matthies C, Tatagiba M (1997) Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 40:696\u2013705. doi:\n                    10.1097\/00006123-199704000-00007\n                    \n                   discussion 705-696","journal-title":"Neurosurgery"},{"key":"9867_CR10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1227\/01.NEU.0000255340.26027.53","volume":"60","author":"D Mathieu","year":"2007","unstructured":"Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ, Lunsford LD (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60:460\u2013468 discussion 468\u2013470","journal-title":"Neurosurgery"},{"key":"9867_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000156907","volume":"21","author":"J Rowe","year":"2008","unstructured":"Rowe J, Radatz M, Kemeny A (2008) Radiosurgery for type II neurofibromatosis. Prog Neurol Surg 21:176\u2013182. doi:\n                    10.1159\/000156907","journal-title":"Prog Neurol Surg"},{"key":"9867_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/cncr.24036","volume":"115","author":"JH Phi","year":"2009","unstructured":"Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW (2009) Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation. Cancer 115:390\u2013398. doi:\n                    10.1002\/cncr.24036","journal-title":"Cancer"},{"key":"9867_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00005072-199303000-00002","volume":"52","author":"RA Sobel","year":"1993","unstructured":"Sobel RA (1993) Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases. J Neuropathol Exp Neurol 52:106\u2013113. doi:\n                    10.1097\/00005072-199303000-00002","journal-title":"J Neuropathol Exp Neurol"},{"key":"9867_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s00428-003-0895-y","volume":"443","author":"J Wechsler","year":"2003","unstructured":"Wechsler J, Lantieri L, Zeller J, Voisin MC, Martin-Garcia N, Wolkenstein P (2003) Aberrant axon neurofilaments in schwannomas associated with phacomatoses. Virchows Arch 443:768\u2013773. doi:\n                    10.1007\/s00428-003-0895-y","journal-title":"Virchows Arch"},{"key":"9867_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0090-3019(96)00487-9","volume":"48","author":"Y Hamada","year":"1997","unstructured":"Hamada Y, Iwaki T, Fukui M, Tateishi J (1997) A comparative study of embedded nerve tissue in six NF2-associated schwannomas and 17 nonassociated NF2 schwannomas. Surg Neurol 48:395\u2013400. doi:\n                    10.1016\/S0090-3019(96)00487-9","journal-title":"Surg Neurol"},{"key":"9867_CR16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3171\/jns.1994.80.3.0541","volume":"80","author":"J Jaaskelainen","year":"1994","unstructured":"Jaaskelainen J, Paetau A, Pyykko I, Blomstedt G, Palva T, Troupp H (1994) Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases. J Neurosurg 80:541\u2013547","journal-title":"J Neurosurg"},{"key":"9867_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-8140(01)00375-9","volume":"60","author":"T Sakamoto","year":"2001","unstructured":"Sakamoto T, Shirato H, Takeichi N, Aoyama H, Fukuda S, Miyasaka K (2001) Annual rate of hearing loss falls after fractionated stereotactic irradiation for vestibular schwannoma. Radiother Oncol 60:45\u201348. doi:\n                    10.1016\/S0167-8140(01)00375-9","journal-title":"Radiother Oncol"},{"key":"9867_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2005.01.055","volume":"63","author":"SE Combs","year":"2005","unstructured":"Combs SE, Volk S, Schulz-Ertner D, Huber PE, Thilmann C, Debus J (2005) Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys 63:75\u201381. doi:\n                    10.1016\/j.ijrobp.2005.01.055","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9867_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-211-78205-7_29","volume":"101","author":"DT Ju","year":"2008","unstructured":"Ju DT, Lin JW, Lin MS, Lee LM, Tseng HM, Wei CP, Yen CH, Hung CC, Hung KS, Lin CM, Lin TJ, Chiu WT, Tsai JT (2008) Hypofractionated CyberKnife stereotactic radiosurgery for acoustic neuromas with and without association to neurofibromatosis Type 2. Acta Neurochir Suppl (Wien) 101:169\u2013173. doi:\n                    10.1007\/978-3-211-78205-7_29","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"9867_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1215\/15228517-2008-021","volume":"10","author":"SM Chang","year":"2008","unstructured":"Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Wen PY, Fine HA, Mehta MP, DeAngelis LM, Lieberman FS, Cloughesy TF, Robins HI, Abrey LE, Prados MD (2008) Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium. Neuro-Oncology 10:631\u2013642. doi:\n                    10.1215\/15228517-2008-021","journal-title":"Neuro-Oncology"},{"key":"9867_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/MOO.0b013e3282b97310","volume":"15","author":"DB Welling","year":"2007","unstructured":"Welling DB, Packer MD, Chang LS (2007) Molecular studies of vestibular schwannomas: a review. Curr Opin Otolaryngol Head Neck Surg 15:341\u2013346. doi:\n                    10.1097\/MOO.0b013e3282b97310","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"9867_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/01.mao.0000180484.24242.54","volume":"27","author":"BA Neff","year":"2006","unstructured":"Neff BA, Welling DB, Akhmametyeva E, Chang LS (2006) The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level. Otol Neurotol 27:197\u2013208. doi:\n                    10.1097\/01.mao.0000180484.24242.54","journal-title":"Otol Neurotol"},{"key":"9867_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00129492-200501000-00017","volume":"26","author":"P Caye-Thomasen","year":"2005","unstructured":"Caye-Thomasen P, Werther K, Nalla A, Bog-Hansen TC, Nielsen HJ, Stangerup SE, Thomsen J (2005) VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 26:98\u2013101. doi:\n                    10.1097\/00129492-200501000-00017","journal-title":"Otol Neurotol"},{"key":"9867_CR24","first-page":"32","volume":"1785","author":"DR Scoles","year":"2008","unstructured":"Scoles DR (2008) The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochim Biophys Acta 1785:32\u201354","journal-title":"Biochim Biophys Acta"},{"key":"9867_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/brain\/awm249","volume":"131","author":"CO Hanemann","year":"2008","unstructured":"Hanemann CO (2008) Magic but treatable? Tumours due to loss of merlin. Brain 131:606\u2013615. doi:\n                    10.1093\/brain\/awm249","journal-title":"Brain"},{"key":"9867_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/mao.0b013e31815d4429","volume":"29","author":"JK Doherty","year":"2008","unstructured":"Doherty JK, Ongkeko W, Crawley B, Andalibi A, Ryan AF (2008) ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy. Otol Neurotol 29:50\u201357","journal-title":"Otol Neurotol"},{"issue":"15 Suppl 1","key":"9867_CR27","first-page":"100s","volume":"26","author":"SR Plotkin","year":"2008","unstructured":"Plotkin SR, Halpin CF, McKenna MJ, Batchelor TT, Loeffler JS, Barker FG (2008) Treatment of progressive NF2-related vestibular schwannoma with erlotinib. J Clin Oncol 26(15 Suppl 1):100s, (Abstract 2045)","journal-title":"J Clin Oncol"},{"key":"9867_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ncponc1157","volume":"5","author":"SR Plotkin","year":"2008","unstructured":"Plotkin SR, Singh MA, O\u2019Donnell CC, Harris GJ, McClatchey AI, Halpin C (2008) Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy. Nat Clin Pract Oncol 5:487\u2013491. doi:\n                    10.1038\/ncponc1157","journal-title":"Nat Clin Pract Oncol"},{"key":"9867_CR29","first-page":"796","volume":"10","author":"SR Plotkin","year":"2008","unstructured":"Plotkin SR, Halpin C, Stemmer-Rachamimoff A, Barker F, Sorensen G, Jain R, Di Tomaso E (2008) Activity of bevacizumab against NF2-related vestibular schwannomas. Neuro-Oncology 10:796. [Abstract ET-51]","journal-title":"Neuro-Oncology"},{"key":"9867_CR30","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1200\/JCO.2005.02.520","volume":"23","author":"B Freidlin","year":"2005","unstructured":"Freidlin B, Simon R (2005) Evaluation of randomized discontinuation design. J Clin Oncol 23:5094\u20135098. doi:\n                    10.1200\/JCO.2005.02.520","journal-title":"J Clin Oncol"},{"key":"9867_CR31","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1200\/JCO.2005.01.149","volume":"23","author":"LV Rubinstein","year":"2005","unstructured":"Rubinstein LV, Korn EL, Freidlin B, Hunsberger S, Ivy SP, Smith MA (2005) Design issues of randomized phase II trials and a proposal for phase II screening trials. J Clin Oncol 23:7199\u20137206. doi:\n                    10.1200\/JCO.2005.01.149","journal-title":"J Clin Oncol"},{"key":"9867_CR32","doi-asserted-by":"crossref","DOI":"10.1201\/9781420036091","volume-title":"Design and analysis of cross-over trials, 2nd edn","author":"B Jones","year":"2003","unstructured":"Jones B, Kenward MG (2003) Design and analysis of cross-over trials, 2nd edn. Chapman & Hall, Boca Raton, FL"},{"key":"9867_CR33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/1535-7163.MCT-06-0249","volume":"6","author":"WM Stadler","year":"2007","unstructured":"Stadler WM (2007) The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents. Mol Cancer Ther 6:1180\u20131185. doi:\n                    10.1158\/1535-7163.MCT-06-0249","journal-title":"Mol Cancer Ther"},{"key":"9867_CR34","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/02841860802213328","volume":"47","author":"AK Koutras","year":"2008","unstructured":"Koutras AK, Mastronikolis NS, Evans TR, Papadeas ES, Makatsoris T, Kalofonos HP (2008) Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer. Acta Oncol 47:1171\u20131173. doi:\n                    10.1080\/02841860802213328","journal-title":"Acta Oncol"},{"key":"9867_CR35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1200\/JCO.1996.14.3.1018","volume":"14","author":"SG Nayfield","year":"1996","unstructured":"Nayfield SG, Gorin MB (1996) Tamoxifen-associated eye disease. A review. J Clin Oncol 14:1018\u20131026","journal-title":"J Clin Oncol"},{"key":"9867_CR36","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/1078-0432.CCR-06-0909","volume":"13","author":"AJ Vickers","year":"2007","unstructured":"Vickers AJ, Ballen V, Scher HI (2007) Setting the bar in phase II trials: the use of historical data for determining \u201cgo\/no go\u201d decision for definitive phase III testing. Clin Cancer Res 13:972\u2013976. doi:\n                    10.1158\/1078-0432.CCR-06-0909","journal-title":"Clin Cancer Res"},{"key":"9867_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0140-6736(00)02528-9","volume":"356","author":"M Buyse","year":"2000","unstructured":"Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P (2000) Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet 356:373\u2013378. doi:\n                    10.1016\/S0140-6736(00)02528-9","journal-title":"Lancet"},{"key":"9867_CR38","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0959-8049(97)00325-0","volume":"33","author":"M Paesmans","year":"1997","unstructured":"Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P, Klastersky J (1997) Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10\u00a0years experience of the European Lung Cancer Working Party. Eur J Cancer 33:2326\u20132332. doi:\n                    10.1016\/S0959-8049(97)00325-0","journal-title":"Eur J Cancer"},{"key":"9867_CR39","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1200\/JCO.2007.10.8407","volume":"26","author":"T Burzykowski","year":"2008","unstructured":"Burzykowski T, Buyse M, Piccart-Gebhart MJ, Sledge G, Carmichael J, Luck HJ, Mackey JR, Nabholtz JM, Paridaens R, Biganzoli L, Jassem J, Bontenbal M, Bonneterre J, Chan S, Basaran GA, Therasse P (2008) Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer. J Clin Oncol 26:1987\u20131992. doi:\n                    10.1200\/JCO.2007.10.8407","journal-title":"J Clin Oncol"},{"key":"9867_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S1470-2045(06)70800-2","volume":"7","author":"KR Johnson","year":"2006","unstructured":"Johnson KR, Ringland C, Stokes BJ, Anthony DM, Freemantle N, Irs A, Hill SR, Ward RL (2006) Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis. Lancet Oncol 7:741\u2013746. doi:\n                    10.1016\/S1470-2045(06)70800-2","journal-title":"Lancet Oncol"},{"key":"9867_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453\u2013461. doi:\n                    10.1016\/S1470-2045(08)70125-6","journal-title":"Lancet Oncol"},{"key":"9867_CR42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.WNL.0000133398.11870.9A","volume":"63","author":"MC Wit de","year":"2004","unstructured":"de Wit MC, de Bruin HG, Eijkenboom W, Sillevis Smitt PA, van den Bent MJ (2004) Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63:535\u2013537","journal-title":"Neurology"},{"key":"9867_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1215\/15228517-2007-062","volume":"10","author":"KR Lamborn","year":"2008","unstructured":"Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD (2008) Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro-Oncology 10:162\u2013170. doi:\n                    10.1215\/15228517-2007-062","journal-title":"Neuro-Oncology"},{"key":"9867_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2407-7-106","volume":"7","author":"VA Levin","year":"2007","unstructured":"Levin VA, Ictech S, Hess KR (2007) Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas. BMC Cancer 7:106. doi:\n                    10.1186\/1471-2407-7-106","journal-title":"BMC Cancer"},{"key":"9867_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1215\/15228517-2006-025","volume":"9","author":"KV Ballman","year":"2007","unstructured":"Ballman KV, Buckner JC, Brown PD, Giannini C, Flynn PJ, LaPlant BR, Jaeckle KA (2007) The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro-Oncology 9:29\u201338. doi:\n                    10.1215\/15228517-2006-025","journal-title":"Neuro-Oncology"},{"key":"9867_CR46","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","volume":"25","author":"H Choi","year":"2007","unstructured":"Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753\u20131759. doi:\n                    10.1200\/JCO.2006.07.3049","journal-title":"J Clin Oncol"},{"key":"9867_CR47","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1200\/JCO.2006.07.3411","volume":"25","author":"RS Benjamin","year":"2007","unstructured":"Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C (2007) We should desist using RECIST, at least in GIST. J Clin Oncol 25:1760\u20131764. doi:\n                    10.1200\/JCO.2006.07.3411","journal-title":"J Clin Oncol"},{"key":"9867_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/cncr.20769","volume":"103","author":"SM Schuetze","year":"2005","unstructured":"Schuetze SM, Rubin BP, Vernon C, Hawkins DS, Bruckner JD, Conrad EU III, Eary JF (2005) Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer 103:339\u2013348. doi:\n                    10.1002\/cncr.20769","journal-title":"Cancer"},{"key":"9867_CR49","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/WCO.0b013e328318402a","volume":"21","author":"ER Gerstner","year":"2008","unstructured":"Gerstner ER, Sorensen AG, Jain RK, Batchelor TT (2008) Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas. Curr Opin Neurol 21:728\u2013735. doi:\n                    10.1097\/WCO.0b013e328318402a","journal-title":"Curr Opin Neurol"},{"key":"9867_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","volume":"11","author":"TT Batchelor","year":"2007","unstructured":"Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83\u201395. doi:\n                    10.1016\/j.ccr.2006.11.021","journal-title":"Cancer Cell"},{"key":"9867_CR51","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/ncponc1204","volume":"5","author":"AG Sorensen","year":"2008","unstructured":"Sorensen AG, Batchelor TT, Wen PY, Zhang WT, Jain RK (2008) Response criteria for glioma. Nat Clin Pract Oncol 5:634\u2013644. doi:\n                    10.1038\/ncponc1204","journal-title":"Nat Clin Pract Oncol"},{"key":"9867_CR52","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/00005537-199606000-00007","volume":"106","author":"MM Abaza","year":"1996","unstructured":"Abaza MM, Makariou E, Armstrong M, Lalwani AK (1996) Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope 106:694\u2013699. doi:\n                    10.1097\/00005537-199606000-00007","journal-title":"Laryngoscope"},{"key":"9867_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00129492-200403000-00012","volume":"25","author":"A Masuda","year":"2004","unstructured":"Masuda A, Fisher LM, Oppenheimer ML, Iqbal Z, Slattery WH (2004) Hearing changes after diagnosis in neurofibromatosis type 2. Otol Neurotol 25:150\u2013154. doi:\n                    10.1097\/00129492-200403000-00012","journal-title":"Otol Neurotol"},{"key":"9867_CR54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1749-4486.2008.01705.x","volume":"33","author":"D Hajioff","year":"2008","unstructured":"Hajioff D, Raut VV, Walsh RM, Bath AP, Bance ML, Guha A, Tator CH, Rutka JA (2008) Conservative management of vestibular schwannomas: third review of a 10-year prospective study. Clin Otolaryngol 33:255\u2013259. doi:\n                    10.1111\/j.1749-4486.2008.01705.x","journal-title":"Clin Otolaryngol"},{"key":"9867_CR55","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1097\/00005537-200011000-00015","volume":"110","author":"DD Massick","year":"2000","unstructured":"Massick DD, Welling DB, Dodson EE, Scholfield M, Nagaraja HN, Schmalbrock P, Chakeres DW (2000) Tumor growth and audiometric change in vestibular schwannomas managed conservatively. Laryngoscope 110:1843\u20131849. doi:\n                    10.1097\/00005537-200011000-00015","journal-title":"Laryngoscope"},{"key":"9867_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00005537-200002010-00012","volume":"110","author":"RM Walsh","year":"2000","unstructured":"Walsh RM, Bath AP, Bance ML, Keller A, Rutka JA (2000) Consequences to hearing during the conservative management of vestibular schwannomas. Laryngoscope 110:250\u2013255. doi:\n                    10.1097\/00005537-200002010-00012","journal-title":"Laryngoscope"},{"key":"9867_CR57","first-page":"722","volume":"21","author":"DC Tschudi","year":"2000","unstructured":"Tschudi DC, Linder TE, Fisch U (2000) Conservative management of unilateral acoustic neuromas. Am J Otol 21:722\u2013728","journal-title":"Am J Otol"},{"key":"9867_CR58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3171\/jns.1997.87.1.0060","volume":"87","author":"P Sampath","year":"1997","unstructured":"Sampath P, Holliday MJ, Brem H, Niparko JK, Long DM (1997) Facial nerve injury in acoustic neuroma (vestibular schwannoma) surgery: etiology and prevention. J Neurosurg 87:60\u201366","journal-title":"J Neurosurg"},{"key":"9867_CR59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","volume":"96","author":"VF Mautner","year":"2002","unstructured":"Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L (2002) Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study. J Neurosurg 96:223\u2013228","journal-title":"J Neurosurg"},{"key":"9867_CR60","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/00129492-200409000-00027","volume":"25","author":"WH Slattery III","year":"2004","unstructured":"Slattery WH III, Fisher LM, Iqbal Z, Oppenhiemer M (2004) Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects. Otol Neurotol 25:811\u2013817. doi:\n                    10.1097\/00129492-200409000-00027","journal-title":"Otol Neurotol"},{"key":"9867_CR61","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/00006123-199211000-00002","volume":"31","author":"ME Linskey","year":"1992","unstructured":"Linskey ME, Lunsford LD, Flickinger JC (1992) Tumor control after stereotactic radiosurgery in neurofibromatosis patients with bilateral acoustic tumors. Neurosurgery 31:829\u2013838. doi:\n                    10.1097\/00006123-199211000-00002\n                    \n                   discussion 838\u2013829","journal-title":"Neurosurgery"},{"key":"9867_CR62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","volume":"96","author":"ME Baser","year":"2002","unstructured":"Baser ME, Makariou EV, Parry DM (2002) Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2. J Neurosurg 96:217\u2013222","journal-title":"J Neurosurg"},{"key":"9867_CR63","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0090-3019(00)00174-9","volume":"53","author":"Y Kida","year":"2000","unstructured":"Kida Y, Kobayashi T, Tanaka T, Mori Y (2000) Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53:383\u2013389. doi:\n                    10.1016\/S0090-3019(00)00174-9\n                    \n                   discussion 389\u2013390","journal-title":"Surg Neurol"},{"key":"9867_CR64","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/jmg.2005.031302","volume":"42","author":"ME Baser","year":"2005","unstructured":"Baser ME, Mautner VF, Parry DM, Evans DG (2005) Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2. J Med Genet 42:903\u2013906. doi:\n                    10.1136\/jmg.2005.031302","journal-title":"J Med Genet"},{"key":"9867_CR65","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/jnnp.74.9.1288","volume":"74","author":"JG Rowe","year":"2003","unstructured":"Rowe JG, Radatz MW, Walton L, Soanes T, Rodgers J, Kemeny AA (2003) Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry 74:1288\u20131293. doi:\n                    10.1136\/jnnp.74.9.1288","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9867_CR66","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/00006123-199105000-00002","volume":"28","author":"JB Bederson","year":"1991","unstructured":"Bederson JB, von Ammon K, Wichmann WW, Yasargil MG (1991) Conservative treatment of patients with acoustic tumors. Neurosurgery 28:646\u2013651. doi:\n                    10.1097\/00006123-199105000-00002","journal-title":"Neurosurgery"},{"key":"9867_CR67","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/01.mao.0000226302.59198.87","volume":"27","author":"A Battaglia","year":"2006","unstructured":"Battaglia A, Mastrodimos B, Cueva R (2006) Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol 27:705\u2013712. doi:\n                    10.1097\/01.mao.0000226302.59198.87","journal-title":"Otol Neurotol"},{"key":"9867_CR68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3171\/jns.2005.103.1.0059","volume":"103","author":"Y Yoshimoto","year":"2005","unstructured":"Yoshimoto Y (2005) Systematic review of the natural history of vestibular schwannoma. J Neurosurg 103:59\u201363","journal-title":"J Neurosurg"},{"key":"9867_CR69","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00005537-200503000-00011","volume":"115","author":"EE Smouha","year":"2005","unstructured":"Smouha EE, Yoo M, Mohr K, Davis RP (2005) Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope 115:450\u2013454. doi:\n                    10.1097\/00005537-200503000-00011","journal-title":"Laryngoscope"},{"key":"9867_CR70","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3171\/jns.2002.96.4.0796","volume":"96","author":"LZ Meiteles","year":"2002","unstructured":"Meiteles LZ, Liu JK, Couldwell WT (2002) Hearing restoration after resection of an intracanalicular vestibular schwannoma: a role for emergency surgery? Case report and review of the literature. J Neurosurg 96:796\u2013800","journal-title":"J Neurosurg"},{"key":"9867_CR71","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1042-3680(18)30196-7","volume":"10","author":"A Niranjan","year":"1999","unstructured":"Niranjan A, Lunsford LD, Flickinger JC, Maitz A, Kondziolka D (1999) Can hearing improve after acoustic tumor radiosurgery? Neurosurg Clin N Am 10:305\u2013315","journal-title":"Neurosurg Clin N Am"},{"key":"9867_CR72","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/00129492-200111000-00035","volume":"22","author":"KR Stidham","year":"2001","unstructured":"Stidham KR, Roberson JB Jr (2001) Hearing improvement after middle fossa resection of vestibular schwannoma. Otol Neurotol 22:917\u2013921. doi:\n                    10.1097\/00129492-200111000-00035","journal-title":"Otol Neurotol"},{"key":"9867_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00405-003-0583-1","volume":"260","author":"Y Inoue","year":"2003","unstructured":"Inoue Y, Ogawa K, Kanzaki J (2003) Hearing improvement after tumor removal in a vestibular schwannoma patient with severe hearing loss. Eur Arch Otorhinolaryngol 260:487\u2013489. doi:\n                    10.1007\/s00405-003-0583-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"9867_CR74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00006123-198008000-00008","volume":"7","author":"G Fischer","year":"1980","unstructured":"Fischer G, Costantini JL, Mercier P (1980) Improvement of hearing after microsurgical removal of acoustic neurinoma. Neurosurgery 7:154\u2013159. doi:\n                    10.1097\/00006123-198008000-00008","journal-title":"Neurosurgery"},{"key":"9867_CR75","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/019459989010300613","volume":"103","author":"C Shelton","year":"1990","unstructured":"Shelton C, House WF (1990) Hearing improvement after acoustic tumor removal. Otolaryngol Head Neck Surg 103:963\u2013965","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9867_CR76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archotol.1988.01860130089021","volume":"114","author":"SA Telian","year":"1988","unstructured":"Telian SA, Kemink JL, Kileny P (1988) Hearing recovery following suboccipital excision of acoustic neuroma. Arch Otolaryngol Head Neck Surg 114:85\u201387","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"9867_CR77","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1158\/1078-0432.CCR-05-1136","volume":"12","author":"R Gray","year":"2006","unstructured":"Gray R, Manola J, Saxman S, Wright J, Dutcher J, Atkins M, Carducci M, See W, Sweeney C, Liu G, Stein M, Dreicer R, Wilding G, DiPaola RS (2006) Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group. Clin Cancer Res 12:1966\u20131969. doi:\n                    10.1158\/1078-0432.CCR-05-1136","journal-title":"Clin Cancer Res"},{"key":"9867_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0194-5998(95)70138-9","volume":"113","author":"S Charabi","year":"1995","unstructured":"Charabi S, Thomsen J, Mantoni M, Charabi B, Jorgensen B, Borgesen SE, Gyldensted C, Tos M (1995) Acoustic neuroma (vestibular schwannoma): growth and surgical and nonsurgical consequences of the wait-and-see policy. Otolaryngol Head Neck Surg 113:5\u201314. doi:\n                    10.1016\/S0194-5998(95)70138-9","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9867_CR79","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0196-0709(00)80050-2","volume":"21","author":"CM Luetje","year":"2000","unstructured":"Luetje CM (2000) Spontaneous involution of acoustic tumors. Am J Otol 21:393\u2013398. doi:\n                    10.1016\/S0196-0709(00)80050-2","journal-title":"Am J Otol"},{"key":"9867_CR80","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2176\/nmc.46.601","volume":"46","author":"Y Yasumoto","year":"2006","unstructured":"Yasumoto Y, Ito M (2006) Spontaneous regression of a growing vestibular schwannoma. Neurol Med Chir (Tokyo) 46:601\u2013604. doi:\n                    10.2176\/nmc.46.601","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"9867_CR81","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/000348949310200705","volume":"102","author":"MI Redleaf","year":"1993","unstructured":"Redleaf MI, McCabe BF (1993) Disappearing recurrent acoustic neuroma in an elderly woman. Ann Otol Rhinol Laryngol 102:518\u2013520","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9867_CR82","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216. doi:\n                    10.1093\/jnci\/92.3.205","journal-title":"J Natl Cancer Inst"},{"key":"9867_CR83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214. doi:\n                    10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","journal-title":"Cancer"},{"key":"9867_CR84","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277\u20131280","journal-title":"J Clin Oncol"},{"key":"9867_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1215\/S1522851705000529","volume":"8","author":"GD Shah","year":"2006","unstructured":"Shah GD, Kesari S, Xu R, Batchelor TT, O\u2019Neill AM, Hochberg FH, Levy B, Bradshaw J, Wen PY (2006) Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro-Oncology 8:38\u201346. doi:\n                    10.1215\/S1522851705000529","journal-title":"Neuro-Oncology"},{"key":"9867_CR86","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00129492-200606000-00018","volume":"27","author":"SE Stangerup","year":"2006","unstructured":"Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J (2006) The natural history of vestibular schwannoma. Otol Neurotol 27:547\u2013552. doi:\n                    10.1097\/00129492-200606000-00018","journal-title":"Otol Neurotol"},{"key":"9867_CR87","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/01.mao.0000169782.69341.6d","volume":"26","author":"AH Marshall","year":"2005","unstructured":"Marshall AH, Owen VM, Nikolopoulos TP, O\u2019Donoghue GM (2005) Acoustic schwannomas: awareness of radiologic error will reduce unnecessary treatment. Otol Neurotol 26:512\u2013515. doi:\n                    10.1097\/01.mao.0000169782.69341.6d","journal-title":"Otol Neurotol"},{"key":"9867_CR88","first-page":"21","volume":"121","author":"RM Walsh","year":"2000","unstructured":"Walsh RM, Bath AP, Bance ML, Keller A, Tator CH, Rutka JA (2000) The natural history of untreated vestibular schwannomas. Is there a role for conservative management? Rev Laryngol Otol Rhinol (Bord) 121:21\u201326","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"key":"9867_CR89","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1227\/01.neu.0000316266.97714.da","volume":"62","author":"GJ Harris","year":"2008","unstructured":"Harris GJ, Plotkin SR, Maccollin M, Bhat S, Urban T, Lev MH, Slattery WH (2008) Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II. Neurosurgery 62:1314\u20131319. doi:\n                    10.1227\/01.neu.0000316266.97714.da\n                    \n                   discussion 1319\u20131320","journal-title":"Neurosurgery"},{"key":"9867_CR90","doi-asserted-by":"publisher","unstructured":"Committee on Hearing and Equilibrium (1995) guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 113:179\u2013180. doi:\n                    10.1016\/S0194-5998(95)70101-X","DOI":"10.1016\/S0194-5998(95)70101-X"},{"key":"9867_CR91","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00701-006-1093-x","volume":"149","author":"PH Roche","year":"2007","unstructured":"Roche PH, Robitail S, Regis J (2007) Two- and three dimensional measures of vestibular schwannomas and posterior fossa\u2014implications for the treatment. Acta Neurochir (Wien) 149:267\u2013273. doi:\n                    10.1007\/s00701-006-1093-x\n                    \n                   discussion 273","journal-title":"Acta Neurochir (Wien)"},{"key":"9867_CR92","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.mao.0000169048.15889.80","volume":"26","author":"WH Slattery","year":"2005","unstructured":"Slattery WH, Lev MH, Fisher LM, Connell SS, Iqbal Z, Go JL (2005) MRI evaluation of neurofibromatosis 2 patients: a standardized approach for accuracy in interpretation. Otol Neurotol 26:733\u2013740. doi:\n                    10.1097\/01.mao.0000169048.15889.80","journal-title":"Otol Neurotol"},{"key":"9867_CR93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3171\/jns.2006.104.1.157","volume":"104","author":"JW Snell","year":"2006","unstructured":"Snell JW, Sheehan J, Stroila M, Steiner L (2006) Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg 104:157\u2013162. doi:\n                    10.3171\/jns.2006.104.1.157","journal-title":"J Neurosurg"},{"key":"9867_CR94","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3174\/ajnr.A0963","volume":"29","author":"JW Henson","year":"2008","unstructured":"Henson JW, Ulmer S, Harris GJ (2008) Brain tumor imaging in clinical trials. AJNR Am J Neuroradiol 29:419\u2013424. doi:\n                    10.3174\/ajnr.A0963","journal-title":"AJNR Am J Neuroradiol"},{"key":"9867_CR95","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/01.wnl.0000243231.12248.67","volume":"67","author":"D Babovic-Vuksanovic","year":"2006","unstructured":"Babovic-Vuksanovic D, Ballman K, Michels V, McGrann P, Lindor N, King B, Camp J, Micic V, Babovic N, Carrero X, Spinner R, O\u2019Neill B (2006) Phase II trial of pirfenidone in adults with neurofibromatosis type 1. Neurology 67:1860\u20131862. doi:\n                    10.1212\/01.wnl.0000243231.12248.67","journal-title":"Neurology"},{"key":"9867_CR96","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pediatrneurol.2007.01.009","volume":"36","author":"D Babovic-Vuksanovic","year":"2007","unstructured":"Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo-Tamula MA, O\u2019Neill BP, Fox E, MacDonald T, Beck H, Packer RJ (2007) Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol 36:293\u2013300. doi:\n                    10.1016\/j.pediatrneurol.2007.01.009","journal-title":"Pediatr Neurol"},{"key":"9867_CR97","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/14992020701355108","volume":"46","author":"JH Barlow","year":"2007","unstructured":"Barlow JH, Turner AP, Hammond CL, Gailey L (2007) Living with late deafness: insight from between worlds. Int J Audiol 46:442\u2013448. doi:\n                    10.1080\/14992020701355108","journal-title":"Int J Audiol"},{"key":"9867_CR98","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1542\/peds.2007-0159","volume":"120","author":"S Petrou","year":"2007","unstructured":"Petrou S, McCann D, Law CM, Watkin PM, Worsfold S, Kennedy CR (2007) Health status and health-related quality of life preference-based outcomes of children who are aged 7 to 9\u00a0years and have bilateral permanent childhood hearing impairment. Pediatrics 120:1044\u20131052. doi:\n                    10.1542\/peds.2007-0159","journal-title":"Pediatrics"},{"key":"9867_CR99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/AUD.0b013e31803126b6","volume":"28","author":"EM Chia","year":"2007","unstructured":"Chia EM, Wang JJ, Rochtchina E, Cumming RR, Newall P, Mitchell P (2007) Hearing impairment and health-related quality of life: the Blue Mountains Hearing Study. Ear Hear 28:187\u2013195. doi:\n                    10.1097\/AUD.0b013e31803126b6","journal-title":"Ear Hear"},{"key":"9867_CR100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/geront\/43.5.661","volume":"43","author":"DS Dalton","year":"2003","unstructured":"Dalton DS, Cruickshanks KJ, Klein BE, Klein R, Wiley TL, Nondahl DM (2003) The impact of hearing loss on quality of life in older adults. Gerontologist 43:661\u2013668","journal-title":"Gerontologist"},{"key":"9867_CR101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1532-5415.1990.tb01595.x","volume":"38","author":"CD Mulrow","year":"1990","unstructured":"Mulrow CD, Aguilar C, Endicott JE, Velez R, Tuley MR, Charlip WS, Hill JA (1990) Association between hearing impairment and the quality of life of elderly individuals. J Am Geriatr Soc 38:45\u201350","journal-title":"J Am Geriatr Soc"},{"key":"9867_CR102","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/010503900750022907","volume":"29","author":"A Ringdahl","year":"2000","unstructured":"Ringdahl A, Grimby A (2000) Severe-profound hearing impairment and health-related quality of life among post-lingual deafened Swedish adults. Scand Audiol 29:266\u2013275. doi:\n                    10.1080\/010503900750022907","journal-title":"Scand Audiol"},{"key":"9867_CR103","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00129492-200503000-00010","volume":"26","author":"K Vermeire","year":"2005","unstructured":"Vermeire K, Brokx JP, Wuyts FL, Cochet E, Hofkens A, Van de Heyning PH (2005) Quality-of-life benefit from cochlear implantation in the elderly. Otol Neurotol 26:188\u2013195. doi:\n                    10.1097\/00129492-200503000-00010","journal-title":"Otol Neurotol"},{"key":"9867_CR104","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00405-005-0987-1","volume":"263","author":"L Lassaletta","year":"2006","unstructured":"Lassaletta L, Castro A, Bastarrica M, de Sarria MJ, Gavilan J (2006) Quality of life in postlingually deaf patients following cochlear implantation. Eur Arch Otorhinolaryngol 263:267\u2013270. doi:\n                    10.1007\/s00405-005-0987-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"9867_CR105","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0194-5998(00)70112-4","volume":"122","author":"YJ Shin","year":"2000","unstructured":"Shin YJ, Fraysse B, Deguine O, Vales O, Laborde ML, Bouccara D, Sterkers O, Uziel A (2000) Benefits of cochlear implantation in elderly patients. Otolaryngol Head Neck Surg 122:602\u2013606. doi:\n                    10.1016\/S0194-5998(00)70112-4","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9867_CR106","doi-asserted-by":"publisher","unstructured":"Metselaar M, Maat B, Krijnen P, Verschuure H, Dreschler WA, Feenstra L (2009) Self-reported disability and handicap after hearing-aid fitting and benefit of hearing aids: comparison of fitting procedures, degree of hearing loss, experience with hearing aids and uni- and bilateral fittings. Eur Arch Otorhinolaryngol. doi: \n                    10.1007\/s00405-008-0847-x","DOI":"10.1007\/s00405-008-0847-x"},{"key":"9867_CR107","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MAO.0b013e318172cfac","volume":"29","author":"WM Klop","year":"2008","unstructured":"Klop WM, Boermans PP, Ferrier MB, van den Hout WB, Stiggelbout AM, Frijns JH (2008) Clinical relevance of quality of life outcome in cochlear implantation in postlingually deafened adults. Otol Neurotol 29:615\u2013621","journal-title":"Otol Neurotol"},{"key":"9867_CR108","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3766\/jaaa.18.2.7","volume":"18","author":"TH Chisolm","year":"2007","unstructured":"Chisolm TH, Johnson CE, Danhauer JL, Portz LJ, Abrams HB, Lesner S, McCarthy PA, Newman CW (2007) A systematic review of health-related quality of life and hearing aids: final report of the American Academy of Audiology Task Force On the Health-Related Quality of Life Benefits of Amplification in Adults. J Am Acad Audiol 18:151\u2013183. doi:\n                    10.3766\/jaaa.18.2.7","journal-title":"J Am Acad Audiol"},{"key":"9867_CR109","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2310\/7070.2003.11435","volume":"32","author":"S Morzaria","year":"2003","unstructured":"Morzaria S, Westerberg BD, Anzarut A (2003) Quality of life following ear surgery measured by the 36-item Short Form Health Survey and the Glasgow Benefit Inventory. J Otolaryngol 32:323\u2013327. doi:\n                    10.2310\/7070.2003.11435","journal-title":"J Otolaryngol"},{"key":"9867_CR110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/14992020309090424","volume":"42","author":"MA Joore","year":"2003","unstructured":"Joore MA, Brunenberg DE, Chenault MN, Anteunis LJ (2003) Societal effects of hearing aid fitting among the moderately hearing impaired. Int J Audiol 42:152\u2013160","journal-title":"Int J Audiol"},{"key":"9867_CR111","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/00016489109130452","volume":"487","author":"K Uyama","year":"1991","unstructured":"Uyama K, Takahashi M, Saito A, Okada Y, Tomizawa I, Kanzaki J (1991) Questionnaire evaluation of balance in the performance of everyday activities after acoustic neuroma surgery. Acta Otolaryngol Suppl 487:91\u201398. doi:\n                    10.3109\/00016489109130452","journal-title":"Acta Otolaryngol Suppl"},{"key":"9867_CR112","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1227\/01.NEU.0000219838.80931.6B","volume":"59","author":"E Myrseth","year":"2006","unstructured":"Myrseth E, Moller P, Wentzel-Larsen T, Goplen F, Lund-Johansen M (2006) Untreated vestibular schwannomas: vertigo is a powerful predictor for health-related quality of life. Neurosurgery 59:67\u201376. doi:\n                    10.1227\/01.NEU.0000219838.80931.6B\n                    \n                   discussion 67\u201376","journal-title":"Neurosurgery"},{"key":"9867_CR113","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1365-2273.2001.00490.x","volume":"26","author":"A McCombe","year":"2001","unstructured":"McCombe A, Baguley D, Coles R, McKenna L, McKinney C, Windle-Taylor P (2001) Guidelines for the grading of tinnitus severity: the results of a working group commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999. Clin Otolaryngol Allied Sci 26:388\u2013393. doi:\n                    10.1046\/j.1365-2273.2001.00490.x","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"9867_CR114","first-page":"421","volume":"18","author":"G Andersson","year":"1997","unstructured":"Andersson G, Ekvall L, Kinnefors A, Nyberg G, Rask-Andersen H (1997) Evaluation of quality of life and symptoms after translabyrinthine acoustic neuroma surgery. Am J Otol 18:421\u2013426","journal-title":"Am J Otol"},{"key":"9867_CR115","first-page":"427","volume":"18","author":"PL Rigby","year":"1997","unstructured":"Rigby PL, Shah SB, Jackler RK, Chung JH, Cooke DD (1997) Acoustic neuroma surgery: outcome analysis of patient-perceived disability. Am J Otol 18:427\u2013435","journal-title":"Am J Otol"},{"key":"9867_CR116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/019459988509300202","volume":"93","author":"JW House","year":"1985","unstructured":"House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146\u2013147","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9867_CR117","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/000348940611500908","volume":"115","author":"L Lassaletta","year":"2006","unstructured":"Lassaletta L, Alfonso C, Del Rio L, Roda JM, Gavilan J (2006) Impact of facial dysfunction on quality of life after vestibular schwannoma surgery. Ann Otol Rhinol Laryngol 115:694\u2013698","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9867_CR118","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/00005537-200405000-00005","volume":"114","author":"JM Ryzenman","year":"2004","unstructured":"Ryzenman JM, Pensak ML, Tew JM Jr (2004) Patient perception of comorbid conditions after acoustic neuroma management: survey results from the acoustic neuroma association. Laryngoscope 114:814\u2013820. doi:\n                    10.1097\/00005537-200405000-00005","journal-title":"Laryngoscope"},{"key":"9867_CR119","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00129492-200604000-00018","volume":"27","author":"D Tufarelli","year":"2006","unstructured":"Tufarelli D, Meli A, Alesii A, De Angelis E, Badaracco C, Falcioni M, Sanna M (2006) Quality of life after acoustic neuroma surgery. Otol Neurotol 27:403\u2013409. doi:\n                    10.1097\/00129492-200604000-00018","journal-title":"Otol Neurotol"},{"key":"9867_CR120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/MAO.0b013e31815a8411","volume":"28","author":"LM Fisher","year":"2007","unstructured":"Fisher LM, Doherty JK, Lev MH, Slattery WH III (2007) Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2. Otol Neurotol 28:1083\u20131090","journal-title":"Otol Neurotol"},{"key":"9867_CR121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/000348948809700110","volume":"97","author":"G Gardner","year":"1988","unstructured":"Gardner G, Robertson JH (1988) Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 97:55\u201366","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9867_CR122","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/000348949610500601","volume":"105","author":"K Robinson","year":"1996","unstructured":"Robinson K, Gatehouse S, Browning GG (1996) Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 105:415\u2013422","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9867_CR123","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/14992020209056074","volume":"41","author":"G Hawthorne","year":"2002","unstructured":"Hawthorne G, Hogan A (2002) Measuring disability-specific patient benefit in cochlear implant programs: developing a short form of the Glasgow Health Status Inventory, the Hearing Participation Scale. Int J Audiol 41:535\u2013544","journal-title":"Int J Audiol"},{"key":"9867_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005537-200111001-00001","volume":"111","author":"MG Stewart","year":"2001","unstructured":"Stewart MG (2001) Outcomes and patient-based hearing status in conductive hearing loss. Laryngoscope 111:1\u201321. doi:\n                    10.1097\/00005537-200111001-00001","journal-title":"Laryngoscope"},{"key":"9867_CR125","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1749-4486.2008.01773.x","volume":"33","author":"F Zhao","year":"2008","unstructured":"Zhao F, Bai Z, Stephens D (2008) The relationship between changes in self-rated quality of life after cochlear implantation and changes in individual complaints. Clin Otolaryngol 33:427\u2013434. doi:\n                    10.1111\/j.1749-4486.2008.01773.x","journal-title":"Clin Otolaryngol"},{"key":"9867_CR126","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/000348940311201111","volume":"112","author":"MR Mahmud","year":"2003","unstructured":"Mahmud MR, Khan AM, Nadol JB Jr (2003) Histopathology of the inner ear in unoperated acoustic neuroma. Ann Otol Rhinol Laryngol 112:979\u2013986","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9867_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000096152","volume":"12","author":"P Caye-Thomasen","year":"2007","unstructured":"Caye-Thomasen P, Dethloff T, Hansen S, Stangerup SE, Thomsen J (2007) Hearing in patients with intracanalicular vestibular schwannomas. Audiol Neurootol 12:1\u201312. doi:\n                    10.1159\/000096152","journal-title":"Audiol Neurootol"},{"key":"9867_CR128","doi-asserted-by":"crossref","unstructured":"Wei BP, Mubiru S, O\u2019Leary S (2006) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev: CD003998","DOI":"10.1002\/14651858.CD003998.pub2"},{"key":"9867_CR129","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1227\/01.NEU.0000194833.66593.8B","volume":"58","author":"BE Pollock","year":"2006","unstructured":"Pollock BE (2006) Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15\u00a0year experience. Neurosurgery 58:241\u2013248. doi:\n                    10.1227\/01.NEU.0000194833.66593.8B\n                    \n                   discussion 241\u2013248","journal-title":"Neurosurgery"},{"key":"9867_CR130","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1227\/01.NEU.0000215947.35646.DD","volume":"58","author":"T Hasegawa","year":"2006","unstructured":"Hasegawa T, Kida Y, Yoshimoto M, Koike J, Goto K (2006) Evaluation of tumor expansion after stereotactic radiosurgery in patients harboring vestibular schwannomas. Neurosurgery 58:1119\u20131128. doi:\n                    10.1227\/01.NEU.0000215947.35646.DD\n                    \n                   discussion 1119\u20131128","journal-title":"Neurosurgery"},{"key":"9867_CR131","first-page":"312","volume":"50","author":"C Delsanti","year":"2004","unstructured":"Delsanti C, Tamura M, Galanaud D, Regis J (2004) Changing radiological results, pitfalls and criteria of failure. Neurochirurgie 50:312\u2013319","journal-title":"Neurochirurgie"},{"key":"9867_CR132","first-page":"1540","volume":"21","author":"H Nakamura","year":"2000","unstructured":"Nakamura H, Jokura H, Takahashi K, Boku N, Akabane A, Yoshimoto T (2000) Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma. AJNR Am J Neuroradiol 21:1540\u20131546","journal-title":"AJNR Am J Neuroradiol"},{"key":"9867_CR133","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jnnp.2007.119602","volume":"79","author":"SY Yang","year":"2008","unstructured":"Yang SY, Kim DG, Chung HT, Park SH, Paek SH, Jung HW (2008) Evaluation of tumour response after gamma knife radiosurgery for residual vestibular schwannomas based on MRI morphological features. J Neurol Neurosurg Psychiatry 79:431\u2013436. doi:\n                    10.1136\/jnnp.2007.119602","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9867_CR134","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1056\/NEJM199811123392003","volume":"339","author":"D Kondziolka","year":"1998","unstructured":"Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426\u20131433. doi:\n                    10.1056\/NEJM199811123392003","journal-title":"N Engl J Med"},{"key":"9867_CR135","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3174\/ajnr.A0969","volume":"29","author":"OW Meijer","year":"2008","unstructured":"Meijer OW, Weijmans EJ, Knol DL, Slotman BJ, Barkhof F, Vandertop WP, Castelijns JA (2008) Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol. AJNR Am J Neuroradiol 29:906\u2013910. doi:\n                    10.3174\/ajnr.A0969","journal-title":"AJNR Am J Neuroradiol"},{"key":"9867_CR136","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00005537-200303000-00006","volume":"113","author":"D Brors","year":"2003","unstructured":"Brors D, Schafers M, Bodmer D, Draf W, Kahle G, Schick B (2003) Postoperative magnetic resonance imaging findings after transtemporal and translabyrinthine vestibular schwannoma resection. Laryngoscope 113:420\u2013426. doi:\n                    10.1097\/00005537-200303000-00006","journal-title":"Laryngoscope"},{"key":"9867_CR137","first-page":"313","volume":"18","author":"JL Weissman","year":"1997","unstructured":"Weissman JL, Hirsch BE, Fukui MB, Rudy TE (1997) The evolving MR appearance of structures in the internal auditory canal after removal of an acoustic neuroma. AJNR Am J Neuroradiol 18:313\u2013323","journal-title":"AJNR Am J Neuroradiol"},{"key":"9867_CR138","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF00588345","volume":"37","author":"M Smith","year":"1995","unstructured":"Smith M, Castillo M, Campbell J, Pillsbury H, Walters T (1995) Baseline and follow-up MRI of the internal auditory canal after suboccipital resection of acoustic schwannoma: appearances and clinical correlations. Neuroradiology 37:317\u2013320. doi:\n                    10.1007\/BF00588345","journal-title":"Neuroradiology"},{"key":"9867_CR139","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.otohns.2008.01.012","volume":"138","author":"ML Bennett","year":"2008","unstructured":"Bennett ML, Jackson CG, Kaufmann R, Warren F (2008) Postoperative imaging of vestibular schwannomas. Otolaryngol Head Neck Surg 138:667\u2013671. doi:\n                    10.1016\/j.otohns.2008.01.012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9867_CR140","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2176\/nmc.39.141","volume":"39","author":"H Umezu","year":"1999","unstructured":"Umezu H, Seki Y (1999) Postoperative magnetic resonance imaging after acoustic neuroma surgery: influence of packing materials in the drilled internal auditory canal on assessment of residual tumor. Neurol Med Chir (Tokyo) 39:141\u2013147. doi:\n                    10.2176\/nmc.39.141\n                    \n                   discussion 147\u2013149","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"9867_CR141","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1044\/jshd.1703.321","volume":"17","author":"IJ Hirsh","year":"1952","unstructured":"Hirsh IJ, Davis H, Silverman SR, Reynolds EG, Eldert E, Benson RW (1952) Development of materials for speech audiometry. J Speech Hear Disord 17:321\u2013337","journal-title":"J Speech Hear Disord"},{"key":"9867_CR142","doi-asserted-by":"crossref","unstructured":"Tillman T, Carhart R (1966) An expanded test for speech discrimination utilizing CNC monosyllabic words. Northwestern University Auditory test #6; Technical Report SAM-TR-66-55. USAF School of Aerospace Medicine, Brooks Air Force Base, TX","DOI":"10.1037\/e464712008-001"},{"key":"9867_CR143","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3109\/00206098409081538","volume":"23","author":"GD Causey","year":"1984","unstructured":"Causey GD, Hood LJ, Hermanson CL, Bowling LS (1984) The Maryland CNC Test: normative studies. Audiology 23:552\u2013568. doi:\n                    10.3109\/00206098409081538","journal-title":"Audiology"},{"key":"9867_CR144","volume-title":"Cuaderno de logoaudiometria","author":"M Cardenas De","year":"1994","unstructured":"De Cardenas M, Marrero V (1994) Cuaderno de logoaudiometria. Universidad Nacional de Educacion a Distancia, Madrid"},{"key":"9867_CR145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-0-387-49979-6_11","volume-title":"Evidence based otolaryngology","author":"C Halpin","year":"2008","unstructured":"Halpin C (2008) Measuring audiometric outcomes. In: Shin J, Hartnick G, Randolph G (eds) Evidence based otolaryngology. Springer, New York, pp 227\u2013238"},{"key":"9867_CR146","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0194-5998(95)70100-1","volume":"113","author":"EM Monsell","year":"1995","unstructured":"Monsell EM (1995) New and revised reporting guidelines from the Committee on Hearing and Equilibrium. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 113:176\u2013178. doi:\n                    10.1016\/S0194-5998(95)70100-1","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9867_CR147","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1044\/jshr.2103.507","volume":"21","author":"AR Thornton","year":"1978","unstructured":"Thornton AR, Raffin MJ (1978) Speech-discrimination scores modeled as a binomial variable. J Speech Hear Res 21:507\u2013518","journal-title":"J Speech Hear Res"},{"key":"9867_CR148","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00129492-200601000-00020","volume":"27","author":"C Halpin","year":"2006","unstructured":"Halpin C, Rauch SD (2006) Using audiometric thresholds and word recognition in a treatment study. Otol Neurotol 27:110\u2013116. doi:\n                    10.1097\/00129492-200601000-00020","journal-title":"Otol Neurotol"},{"key":"9867_CR149","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00129492-200305000-00018","volume":"24","author":"A Aronzon","year":"2003","unstructured":"Aronzon A, Ruckenstein MJ, Bigelow DC (2003) The efficacy of corticosteroids in restoring hearing in patients undergoing conservative management of acoustic neuromas. Otol Neurotol 24:465\u2013468. doi:\n                    10.1097\/00129492-200305000-00018","journal-title":"Otol Neurotol"},{"key":"9867_CR150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/000348940311200501","volume":"112","author":"BI Nageris","year":"2003","unstructured":"Nageris BI, Popovtzer A (2003) Acoustic neuroma in patients with completely resolved sudden hearing loss. Ann Otol Rhinol Laryngol 112:395\u2013397","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"9867_CR151","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF02940237","volume":"165","author":"RJ Gaffney","year":"1996","unstructured":"Gaffney RJ, McShane DP (1996) Bilateral acoustic neurofibromatosis camouflaged by corticosteroid treatment of sudden sensorineural hearing loss. Ir J Med Sci 165:151\u2013152. doi:\n                    10.1007\/BF02940237","journal-title":"Ir J Med Sci"},{"key":"9867_CR152","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/archderm.123.8.1011","volume":"123","author":"VM Riccardi","year":"1987","unstructured":"Riccardi VM (1987) Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol 123:1011\u20131016. doi:\n                    10.1001\/archderm.123.8.1011","journal-title":"Arch Dermatol"},{"key":"9867_CR153","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/019459988809800401","volume":"98","author":"RA Jahrsdoerfer","year":"1988","unstructured":"Jahrsdoerfer RA, Benjamin RS (1988) Chemotherapy of bilateral acoustic neuromas. Otolaryngol Head Neck Surg 98:273\u2013282","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9867_CR154","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.2007.13.5913","volume":"26","author":"RH El-Maraghi","year":"2008","unstructured":"El-Maraghi RH, Eisenhauer EA (2008) Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III. J Clin Oncol 26:1346\u20131354. doi:\n                    10.1200\/JCO.2007.13.5913","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-009-9867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-009-9867-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-009-9867-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-009-9867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T16:15:33Z","timestamp":1581956133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-009-9867-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["9867"],"URL":"https:\/\/doi.org\/10.1007\/s11060-009-9867-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}